IDIOPATHIC PULMONARY FIBROSIS

This study is testing whether a purified compound from green tea, called EGCG, is safe for people with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. It will involve about 50 patients who are already taking standard IPF medications. Researchers will give pa…

This study is testing whether a new drug called LYT-100 can slow the decline of lung function in people with idiopathic pulmonary fibrosis (IPF), a serious scarring lung disease. It compares LYT-100 against an existing drug (pirfenidone) and a placebo in 240 adults who haven't be…

This study follows people who were in previous trials of an inhaled medication called treprostinil for progressive lung scarring diseases. It aims to check the long-term safety and side effects of the drug over up to six years. Only people who completed specific earlier studies a…

This study is testing whether a new drug called ENV-101 can help slow down lung scarring and improve breathing in adults with idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 213 participants will receive either one of three doses of ENV-101 or a placebo for six…

This early-stage study is testing whether atezolizumab, a drug approved for cancer, is safe and might help people with idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. It will involve about 24 adults aged 50-80 with IPF who can continue their standard medicat…

This large Phase 3 study is testing whether the investigational drug BMS-986278 can safely slow the progression of idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. It involves about 1,255 adults with IPF who will receive either the drug or a placebo. Research…

This study is testing whether a special type of MRI scan, which uses inhaled xenon gas, can help doctors see how well the lungs are working in people with Idiopathic Pulmonary Fibrosis (IPF). Researchers want to see if this scan can detect changes in lung function over time as pa…

This study aims to find a marker in the blood that could help doctors detect idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease, earlier. Researchers are comparing blood samples from 450 people: those with IPF, those with other lung diseases, and healthy individ…

This study is testing a special type of MRI scan to see if it can detect changes in lung scarring. It will enroll 60 adults with progressive lung scarring who are starting or considering anti-scarring medication. Participants will have the MRI scan before starting treatment and a…

This study aims to understand how long patients with lung scarring diseases like Idiopathic Pulmonary Fibrosis (IPF) continue taking their antifibrotic medications in real-world French healthcare settings. It will follow over 10,000 patients who started treatment between 2018 and…

This study is testing a new type of imaging scan to see if it can detect changes in lung scarring caused by a compound from green tea (EGCG). Up to 22 people with Idiopathic Pulmonary Fibrosis (IPF) will get two special PET scans to measure collagen in their lungs. The goal is to…